十大新兴技术聚焦健康，技术融合重塑行业格局

Group 1 - The report identifies ten emerging technologies expected to have significant impacts in the next three to five years, particularly in healthcare, including nanoenzymes, engineered living therapies, GLP-1 drugs for neurodegenerative diseases, and autonomous biochemical sensing [1][2] - The focus on chronic disease management is emphasized, with a large patient base in China facing challenges from aging and younger populations suffering from chronic conditions [3][4] - The global market for nanoenzymes is projected to grow from $5.13 billion in 2024 to $57.95 billion by 2034, reflecting a compound annual growth rate of 27.4% [4] Group 2 - GLP-1 drugs are gaining attention for their potential applications beyond diabetes, including treatment for Alzheimer's and Parkinson's diseases, with a projected market growth to $55.7 billion by 2031 [5] - The report highlights the importance of automated biochemical sensing technology and engineered living therapies in managing chronic diseases, with wearable glucose sensors being a successful application [5][6] - The integration of various technologies, such as engineered living therapies and nanoenzymes, is seen as crucial for addressing health and sustainability challenges [7][8] Group 3 - The report calls for collaboration among business, government, and scientific communities to support the commercialization and responsible governance of these emerging technologies [8] - The global synthetic biology market is expected to grow from $17 billion in 2023 to nearly $50 billion by 2028, with the health sector representing the largest share [9]